View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 15, 2019

EIT Health Accelerator programme recognised by UBI Global

The European Institute of Innovation and Technology Health (EIT Health) has had its accelerator programme recognised by Stockholm-based innovation intelligence company UBI Global in its latest World Benchmark Study of business incubation.

By Chloe Kent

The European Institute of Innovation and Technology Health (EIT Health) has had its accelerator programme recognised by Stockholm-based innovation intelligence company UBI Global in its latest World Benchmark Study of business incubation.

The accelerator was recognised in the study’s ‘most promising – young programme’ category, which assesses accelerators that have been operating for three years or less upon submission.

EIT Health Accelerator is a business creation programme set up to support health industry entrepreneurs and start-ups by providing skills and services to develop competitive new companies.

Over the past three years, EIT Health-supported start-ups have attracted more than €90m in investment, with the accelerator programme supporting over 400 start-ups. This includes companies such as Diabeloop, which has developed an artificial pancreas system for diabetes, and Peptomyc, which is investigating potential new cancer treatments.

EIT Health director of business creation and UBI Global research advisory board member Dr Kurt Höller said: “It is fantastic to be recognised at this stage of the journey for our programme. We’re proud of what we’ve achieved in just three years and the fact that we are able to tangibly demonstrate our performance and impact. The recognition demonstrates that our extensive network – including key mentors, investors and industry players – really does provide the access, exposure and support that promising new ventures need.

“EIT Health is well on the way to becoming one of the leading business creation programmes in healthcare, globally – we are looking forward to seeing what we can achieve in our next three years.”

The UBI Global World Benchmark Study looks at business incubation and acceleration on a global scale.

UBI Global director of research Holger Meyer said: “Following a rigorous data-driven approach, we assessed and benchmarked incubation programmes across the world. Our World Benchmark Study 2019 – 2020 is in tune with the multiple facets of the international incubation ecosystem and illustrates key challenges and opportunities faced by the participating programmes.”

In the 2019-2020 report, 364 programmes have been recognised. The recognitions and announcements took place at the World Incubation Summit 2019 in Doha, Qatar on 6 November.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network